Seminars in Oncology
Volume 33, Issue 2 , Pages 195-201 , April 2006

Familial Chronic Lymphocytic Leukemia

  • Gabrielle S. Sellick

      Affiliations

    • Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.
    • ,
  • Daniel Catovsky

      Affiliations

    • Section of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK.
    • ,
  • Richard S. Houlston

      Affiliations

    • Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.
    • Corresponding Author InformationAddress correspondence to Dr Richard Houlston, Institute of Cancer Research, 15 Cotswold Rd, Sutton, Surrey SM2 5NG, UK.

References 

  1. Miller BA , Ries LAG , Hankey BF , et al.   Cancer Statistics Review 1973-90, NIH Publication No. 93:2789 . Bethesda, MD: National Cancer Institute; 1993;
  2. Gale RP , Foon KA . Biology of chronic lyphocytic leukemia . Semin Hematol . 1987;24:209–229
  3. Houlston RS , Sellick G , Yuille M , et al.   Causation of chronic lymphocytic leukemia—Insights from familial disease . Leuk Res . 2003;27:871–876
  4. Videbaek A . Hereditary in Human Leukaemia and Its Relation to Cancer (A Genetic and Clinical Study of 209 Probands) . Copenhagen, Denmark: Nyt Nordisk Forlag, Arnold Busck; 1947;
  5. Jonsson V , Houlston RS , Catovsky D , et al.   CLL family ’Pedigree 14’ revisited (1947-2004 Leukemia) . 2005;19:1025–1028
  6. Gunz FW , Gunz JP , Veale AM , et al.   Familial leukemia (A study of 909 families) . Scand J Haematol . 1975;15:117–131
  7. Giles GG , Lickiss JN , Baikie MJ , et al.   Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-1980 (Occupational and familial aspects) . J Natl Cancer Inst . 1984;72(1124):1233
  8. Cartwright RA , Bernard SM , Bird CC , et al.   Chronic lymphocytic leukemia (Case-control epidemiological study in Yorkshire) . Br J Cancer . 1987;56:79–82
  9. Linet MS , Van Natta ML , Brookmeyer R , et al.   Familial cancer history and chronic lymphocytic leukemia. A case-control study . Am J Epidemiol . 1989;130:655–664
  10. Pottern LM , Linet M , Blair A , et al.   Familial cancers associated with subtypes of leukamia and non-Hodgkin’s lymphoma . Leuk Res . 1991;15:305–314
  11. Goldgar DE , Easton DF , Cannon-Albright LA , et al.   Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands . J Natl Cancer Inst . 1994;86:1600–1608
  12. Radovanovic Z , Markovic-Denic L , Jakovic S . Cancer mortality of family members of patients with chronic lymphocytic leukemia . Eur J Epidemiol . 1994;10:211–213
  13. Goldin LR , Pfeiffer RM , Li X , et al.   Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia (Results from the Swedish Family-Cancer Database) . Blood . 2004;104:1850–1854
  14. Ishibe N , Sgambati MT , Fontaine L , et al.   Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry . Leuk Lymphoma . 2001;42:99–108
  15. Ries LAG, Eisner MP, Kosary CL, et al: SEER Cancer Statistics Review 1975-2000. Bethesda, MD, National Cancer Institute, http://seer.cancer.gov/csr/1975_2000
  16. Horwitz M , Goode EL , Jarvik GP . Anticipation in familial leukemia . Am J Hum Genet . 1996;59:990–998
  17. Yuille MR , Houlston RS , Catovsky D . Anticipation in familial chronic lymphocytic leukemia families . Leukemia . 1998;12:1696–1698
  18. Goldin LR , Sgambati M , Marti GE , et al.   Anticipation in familial chronic lymphocytic leukemia . Am J Hum Genet . 1999;65:265–269
  19. Wiernik PH , Ashwin M , Hu XP , et al.   Anticipation in familial chronic lymphocytic leukemia . Br J Haematol . 2001;113:407–414
  20. Daugherty SE , Pfeiffer RM , Mellemkjaer L , et al.   No evidence for anticipation in lymphoproliferative tumors in population-based samples . Cancer Epidemiol Biomarkers Prev . 2005;14:1245–1250
  21. Pritsch O , Troussard X , Magnac C , et al.   VH gene usage by family members affected with chronic lymphocytic leukemia . Br J Haematol . 1999;107:616–624
  22. Sakai A , Marti GE , Caporaso N , et al.   Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL . Blood . 2000;95:1413–1419
  23. Rawstron AC , Green MJ , Kuzmicki A , et al.   Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts . Blood . 2002;100:635–639
  24. Rawstron AC , Yuille MR , Fuller J , et al.   Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion . Blood . 2002;100:2289–2290
  25. Rawstron AC , de Tute R , Cullen MJ , et al.   Sub-clinical CLL is found in a high proportion of “normal” relatives from CLL families (Young adults show the highest relative risk) . Blood . 2002;100:167; (letter)
  26. Marti GE , Carter P , Abbasi F , et al.   B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia . Cytometry . 2003;52B:1–12
  27. Risch N , Merikangas K . The future of genetic studies of complex human diseases . Science . 1996;273:1516–1517
  28. Sellick GS , Allinson R , Matutes E , et al.   Increased sex concordance of sibling pairs with chronic lymphocytic leukemia . Leukemia . 2004;18:1162–1163
  29. Horwitz M , Wiernik PH . Pseudoautosomal linkage of Hodgkin disease . Am J Hum Genet . 1999;65:1413–1422
  30. Gunz FW , Veale AMO . Leukemia in close relatives—Accident or predisposition? . J Natl Cancer Inst . 1969;42:517–524
  31. Jarrett RF , Krajewski AS , Angus B , et al.   The Scotland and Newcastle epidemiological study of Hodgkin’s disease (Impact of histopathological review and EBV status on incidence estimates) . J Clin Pathol . 2003;56:811–816
  32. Klitz W , Aldrich CL , Fildes N , et al.   Localization of predisposition to Hodgkin disease in the HLA class II region . Am J Hum Genet . 1994;54:497–505
  33. Ebers GC , Dyment DA . Genetics of multiple sclerosis . Semin Neurol . 1998;18:295–299
  34. Verity DH , Marr JE , Ohno S , et al.   Bechet’s disease, the Silk Road and HLA-B51 (Historical and geographical perspectives) . Tissue Antigens . 1999;54:213–220
  35. Rossman MD , Thompson B , Frederick M , et al.   HLA-DRB1*1101 (A significant risk factor for sarcoidosis in blacks and whites) . Am J Hum Genet . 2003;73:720–735
  36. Mueller LP , Machulla HK . Increased frequency of homozygosity for HLA class II loci in female patients with chronic lymphocytic leukemia . Leuk Lymphoma . 2002;43:1013–1019
  37. Hakim I , Brok-Simoni F , Grossman Z , et al.   CLL in three sisters (Preferred usage of specific IG gene segments) . Eur J Cancer . 1993;29A(suppl 6):S38
  38. Goldin LR , Ishibe N , Sgambati M , et al.   A genome scan of 18 families with chronic lymphocytic leukemia . 2003;121: 866 873
  39. Sellick GS , Webb EL , Allinson R , et al.   A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci . Am J Hum Genet . 2005;77:420–429
  40. Risch N . Assessing the role of HLA-linked and unlinked determinants of disease . Am J Hum Genet . 1987;40:1–14
  41. Okada T , Takiura F , Tokushige K , et al.   Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice (A model for B cell chronic lymphocytic leukemia and autoimmune disease) . Eur J Immunol . 1991;21:2743–2748
  42. Hirose S , Hamano Y , Shirai T . Genetic factors predisposing to B-CLL and to autoimmune disease in spontaneous murine model . Leukemia . 1997;11(suppl 3):267–270
  43. Machulla HK , Muller LP , Schaaf A , et al.   Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients . 2001;92:203–207
  44. Wiley JS , Dao-Ung LP , Gu BJ , et al.   A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukemia (A molecular study) . Lancet . 2002;359:1114–1119
  45. Calin GA , Trapasso F , Shimizu MD , et al.   Familial cancer associated with a polymorphism in ARLTS1 . N Engl J Med . 2005;352:1667–1676
  46. Dasgupta RK , Rollinson S , O’Connor S , et al.   No effect of the P2X7 receptor polymorphism on risk of CLL or outcome from therapy in the UK population . Br J Haematol . 2003;121(suppl 1):26
  47. Thunberg U , Tobin G , Johnson A , et al.   Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukemia . Lancet . 2002;360:1935–1939
  48. Zhang LY , Ibbotson RE , Orchard JA , et al.   P2X7 polymorphism and chronic lymphocytic leukemia (Lack of correlation with incidence, survival and abnormalities of chromosome 12) . Leukemia . 2003;17:2097–2100
  49. Starczynski J , Pepper C , Pratt G , et al.   The P2X7 receptor gene polymorphism 1513 A→C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukemia . Br J Haematol . 2003;123:66–71
  50. Sellick GS , Rudd M , Eve P , et al.   The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia . Cancer Epidemiol Biomarkers Prev . 2004;13:1065–1067
  51. Meijers-Heijboer H , van den Ouweland A , Klijn J , et al.   Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations . Nat Genet . 2002;31:55–59
  52. Hiramoto T , Nakanishi T , Sumiyoshi T , et al.   Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer . Oncogene . 1999;18:3422–3426
  53. Bello VE , Aloyz RS , Christodoulopoulos G , et al.   Homologous recombinational repair vis-a-vis chlorambucil resistance in chronic lymphocytic leukemia . Biochem Pharmacol . 2002;63:1585–1588
  54. Steffen J , Varon R , Mosor M , et al.   Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland . Int J Cancer . 2004;111:67–71
  55. Stankovic T , Hubank M , Cronin D , et al.   Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses . Blood . 2004;103:291–300
  56. Pettitt AR , Sherrington PD , Stewart G , et al.   p53 dysfunction in B-cell chronic lymphocytic leukemia (Inactivation of ATM as an alternative to TP53 mutation) . Blood . 2001;98:814–822
  57. Yuille MR , Condie A , Hudson CD , et al.   ATM mutations are rare in familial chronic lymphocytic leukemia . Blood . 2002;100:603–609
  58. Ishibe N , Goldin LR , Caporaso NE , et al.   ATM mutations and protein expression are not associated with familial B-CLL cases . Leuk Res . 2003;27:973–975
  59. Summersgill B , Thornton P , Atkinson S , et al.   Chromosomal imbalances in familial chronic lymphocytic leukemia (A comparative genomic hybridisation analysis) . Leukemia . 2002;16:1229–1232

 Supported by the Leukemia Research and the Arbib Foundation.

PII: S0093-7754(06)00022-4

doi: 10.1053/j.seminoncol.2006.01.013

Seminars in Oncology
Volume 33, Issue 2 , Pages 195-201 , April 2006

Article Tools

* Image Usage & Resolution